Page Content (Right Column)
If you've consulted our FAQs and our expanded information on the disorder and still have questions regarding hemochromatosis, you can contact our office toll-free in Canada at 1-877-BAD-IRON (1-877-223-4766) or by e-mail at firstname.lastname@example.org.
Get the free Acrobat Reader by visiting the Adobe web site.
Hereditary hemochromatosis is caused by defects in a gene called HFE. DNA testing can confirm the presence of the three mutations which are known to cause hemochromatosis: C282Y, H63D and S65C. DNA testing can be done to find out if your family may be at risk.
A confidential HFE genetic testing using buccal (mouth) swab collection is available through Genetrack Biolabs at www.hemochromatosisdna.com.
Page Content (Middle Column)
This page is also available as a printable PDF: FAQs
See The Disorder section of this site for more detailed information on each of the issues below.
Hereditary hemochromatosis (HHC), or iron overload, is an inherited disorder that causes the body to absorb two to three times the normal amount of iron. Over the years, the excess iron builds up in the vital organs, joints and tissues where it can cause a number of debilitating and potentially fatal conditions such as liver and heart disease, diabetes, impotence and arthritis.
Hereditary hemochromatosis is the most common genetic disorder affecting Canadians. One in nine people of mostly Northern European descent are carriers of the most common type of HHC and 1 in 300 are estimated to have two copies of the gene that puts them at risk for iron overload. Up until recently, medical professionals were taught this was an extremely rare disorder, so your doctor may not be aware of it.
Because early symptoms can be non-specific and attributed to many other causes, hemochromatosis can be difficult to diagnose until more extensive damage has occurred. Even then, hemochromatosis is often overlooked as the causative factor in an observable disease.
Some early symptoms include:
Later symptoms may include:
Yes. A simple blood test can detect iron overload, but it is NOT part of the standard blood test ordered in conjunction with an annual check-up. Your doctor must specifically request an iron series profile on the lab requisition form. It measures the amount of iron in the various iron storage and transport proteins in your blood to give a picture of how much iron is stored in your body. This is NOT the same as hemoglobin. If iron levels are elevated, DNA or genetic testing for the most common type of HHC is available and may be used to confirm a diagnosis. If your iron levels are significantly elevated, your physician may also wish to do additional testing to establish the level of damage on the liver.
Yes. Currently, the primary treatment consists of the removal of blood (like a blood donation, only more frequent) at regular intervals until iron levels return to normal. Once normal iron levels are re-established, they can be maintained by periodic blood removal (2 to 6 times a year depending on the individual). During this maintenance phase, if eligible, blood can be donated through the Canadian Blood Services (CBS). Treatment will prevent damage that would have been caused by iron overload, and is ongoing for life.
Not everyone with both copies of the defective gene develops hemochromatosis and, if they do, the degree of iron overload varies. However, once a person exhibits symptoms of iron overload, the disease process can only be arrested by removal of the underlying cause, which is too much iron. Left too long, many symptoms such as cirrhosis of the liver, heart disease, and diabetes will be irreversible and can lead to early death. Treated before damage occurs, disease need never occur.
HHC is a genetic disorder, so all of your first degree relatives should also be tested for elevated iron levels. Parents, siblings and adult children may want to confirm their genetic status to evaluate their risk of developing iron overload if their initial blood tests reveal normal iron levels. Spouses should be tested to help evaluate the potential risk to minor children.
The Canadian Hemochromatosis Society was established to create awareness about this little-known disorder so that early diagnosis would become the rule rather than the exception, and so that needless suffering and premature death from undiagnosed hemochromatosis would become a thing of the past. In the meantime, we are here to provide information and support to those adversely affected by iron overload.